Tags |
|
|
Links |
|
|
Just Other Articles - Publicity: Nailing a Media Interview, Part I
The most important thing to remember for any interview: stay
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
on topic. I ask clients to repeat this like a mantra before
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
they go on the air, or even when on the phone with a reporte
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
.
A print reporter gets maybe 700 words to do your story. A
A print reporter gets maybe 700 words to do your story. A
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
TV or radio reporter has two minutes. So your interview shou
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ldn't be hours long.
Don’t give them more than they need. I
Don’t give them more than they need. I
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
’s too overwhelming for them, and can divert the story to a
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
angent. Tangents have a place – in intellectual dialogue; wh
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
n you’re talking among colleagues. Remember this formula alw
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ays: in mediaworld, almost all the time, tangent = someone e
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
se’s story, not yours, getting talked about.
Sure, you can
Sure, you can
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ecome a reporter’s friend by steering them to new resources,
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
trends, and information. But don’t feel obligated to point o
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ut all opposing points of view, or to lead them to those who
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
may dispute you. Who needs that?
Remember... becoming buddi
Remember... becoming buddi
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
s with the press is a good thing – but our ultimate goal is
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
o attract prospects and clients.
To avoid these pitfalls, p
To avoid these pitfalls, p
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ractice your answers to the questions you expect before the
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
nterview. Whether it’s on- or off-camera, your interview has
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
no “do-overs.” So make your mistakes while practicing for it
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/33989/justotherarticles-Publicity-Nailing-a-Media-Interview-Part-I.html">Publicity: Nailing a Media Interview, Part I</a>
BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/33989/justotherarticles-Publicity-Nailing-a-Media-Interview-Part-I.html]Publicity: Nailing a Media Interview, Part I[/url]
Related Articles:
Feel the Fear and Do It Anyway
Tips for Finding the Perfect Partner
Holly Mann- Is She Legit, Or Another Get Rich Quick Scam?
Bookmark it:
|